David McClung

Track

Insider profile

Currently holds a position at BioCardia Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer BioCardia Inc Jan. 1, 2019 -
Chief Financial Officer BioCardia Inc Sept. 1, 2017 - Jan. 1, 2019
Principal Financial and Accounting Officer, Vice President - Finance BioCardia Inc Oct. 24, 2016 - Sept. 1, 2017
Vice President - Finance BioCardia Inc March 1, 2016 - Oct. 24, 2016
David McClung's trades of BioCardia Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US BioCardia Inc (BCDA)
Transaction date
Purchase
Price
452.95
Quantity 62,633 +1.6%
Value US$2,756,919
US BioCardia Inc (BCDA)
Transaction date
Purchase
Price
391.66
Quantity 5,256 -16.8%
Value US$4,356,008
US BioCardia Inc (BCDA)
Transaction date
Purchase
Price
477.37
Quantity 76,997 +48.8%
Value US$3,385,048
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-02 2025-06-30
US BioCardia Inc (BCDA)
B Purchase
62,633 +1.6%
452.95
US$2,756,919 		62,633 +1.6% 452.95 US$2,756,919
2025-04-25 2025-04-23
US BioCardia Inc (BCDA)
B Purchase
5,256 -16.8%
391.66
US$4,356,008 		5,256 -16.8% 391.66 US$4,356,008
2022-10-11 2022-10-10
US BioCardia Inc (BCDA)
B Purchase
76,997 +48.8%
477.37
US$3,385,048 		76,997 +48.8% 477.37 US$3,385,048